Private Grant  awarded by ORTHO-MCNEIL, INC. 2011 - 2015

Private Grant  awarded by Janssen 2013 - 2014

Private Grant  awarded by LIVANOVA USA, INC. 2020 - 2025

Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease(A4 Study)  awarded by University of Southern California 2016 - 2024

Combination Anti-Amyloid Therapy for Preclinical Alzheimer's Disease  awarded by University of Southern California 2019 - 2024

Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2020 - 2023

The A3 Study: Ante-Amyloid Prevention of Alzheimer's Disease  awarded by University of Southern California 2019 - 2023

Private Grant  awarded by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. ^ 2020 - 2022

A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of 2 Potential Disease Modifying Therapies in Individuals at Risk for and with Dominantly Inherited Alzheimer’s Disease  awarded by Washington University 2013 - 2022

Private Grant  awarded by OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC 2020 - 2022

AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer’s Disease and Elevated Amyloid (A45 Trial) and in Subjects With Early Preclinical Alzheimer’s Disease and Intermediate Amyloid (A3 Trial)  awarded by University of Southern California 2020 - 2022

Private Grant  awarded by Genentech 2018 - 2022

Private Grant  awarded by BIOGEN MA INC 2018 - 2022

Alzheimer's Disease Neuroimaging Initiative 3 (ADNl3)  awarded by University of Southern California 2016 - 2022

Private Grant  awarded by EISAI, INC. 2013 - 2022

A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multicenter Study of Potential Disease Modifying Therapies in Individuals at Risk for and with Dominantly Inherited Alzheimer’s Disease (“Protocol”).  awarded by Washington University 2018 - 2022

Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study  awarded by University of Southern California 2019 - 2021

Private Grant  awarded by BIOGEN MA INC 2014 - 2021

Private Grant  awarded by Janssen 2016 - 2021

Private Grant  awarded by Janssen 2016 - 2021

Private Grant  awarded by NEURORX 2020 - 2021

Private Grant  awarded by NEURORX 2020 - 2021

Augmentation Versus Switch: Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders with Treatment Resistant Depression (ASCERTAIN-TRD)  awarded by PATIENT CENTERED OUTCOMES RESEARCH INSTITUTE 2017 - 2020

Private Grant  awarded by OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC 2018 - 2020

Private Grant  awarded by BIOGEN, INC. 2018 - 2020

Private Grant  awarded by ACADIA PHARMACEUTICALS, INC. 2020

Private Grant  awarded by ACADIA PHARMACEUTICALS, INC. 2019 - 2020

Balanced Placebo Design with Varenicline: Pharmacological and Expectancy Effects on Medication Adherence  awarded by National Institute on Drug Abuse/NIH/DHHS 2018 - 2020

Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2016 - 2020

Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION - NEW 2019 - 2020

Private Grant  awarded by ACADIA PHARMACEUTICALS, INC. 2017 - 2019

Private Grant  awarded by BIOGEN, INC. 2016 - 2019

Private Grant  awarded by ALLERGAN, INC. 2018 - 2019

Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2016 - 2019

Private Grant  awarded by ALLERGAN, INC. 2019

Private Grant  awarded by INTRA-CELLULAR THERAPIES INC. 2018 - 2019

Private Grant  awarded by ALLERGAN SALES, LLC 2017 - 2019

Private Grant  awarded by ALLERGAN SALES, LLC 2017 - 2019

Private Grant  awarded by NAVITOR PHARMACEUTICALS INC. 2019

Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2017 - 2019

Private Grant  awarded by NEURORX 2017 - 2019

Private Grant  awarded by ALLERGAN SALES, LLC 2017 - 2019

Private Grant  awarded by H. LUNDBECK A/S 2014 - 2019

Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2015 - 2018

A Placebo-Controlled, Crossover Study of Fanapt® (iloperidone) Augmentation of SSRIs for Residual Anger and Irritability in Major Depressive Disorder  awarded by MASSACHUSETTS GENERAL HOSPITAL 2013 - 2018

Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2015 - 2018

Private Grant  awarded by H. LUNDBECK A/S 2014 - 2018

Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2015 - 2018

Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2017 - 2018

Private Grant  awarded by ALLERGAN, INC. 2016 - 2018

Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2015 - 2018

Private Grant  awarded by ALKERMES, INC. 2014 - 2017

Private Grant  awarded by FOREST LABORATORIES, INC. 2014 - 2017

Private Grant  awarded by NAUREX, INC. 2012 - 2017

Private Grant  awarded by NAUREX, INC. 2014 - 2017

Private Grant  awarded by ALKERMES, INC. 2014 - 2017

Private Grant  awarded by TAL MEDICAL 2013 - 2017

Private Grant  awarded by GENOMIND 2016

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study: A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial  awarded by University of Southern California 2015 - 2016

Alzheimer's Disease Neuroimaging Initiative 2 (ADNI2)  awarded by University of Southern California 2015 - 2016

Alzehimer's Disease Neuroimaging Initiative (ADNI)  awarded by University of California, San Diego 2005 - 2016

Private Grant  awarded by OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC 2012 - 2016

Double-Blind, Placebo-Controlled, Proof-of-Concept (POC) Trial of CERC-501, a Kappa-Selective Opioid Receptor Antagonist, Augmentation of Antidepressant Therapy in Treatment-Resistant Depression (TRD)  awarded by MASSACHUSETTS GENERAL HOSPITAL 2015 - 2016

Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2014 - 2016

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - The LEARN Study A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial  awarded by University of California, San Diego 2015

Private Grant  awarded by ASSUREX HEALTH INC. 2014 - 2015

Alzheimer's Disease Cooperative Study  awarded by University of California, San Diego 2013 - 2015

Private Grant  awarded by AVANIR PHARMACEUTICALS, INC. 2014 - 2015

Private Grant  awarded by TAKEDA GLOBAL RESEARCH & DEVELOPMENT CENTER 2012 - 2015

Private Grant  awarded by TAKEDA GLOBAL RESEARCH & DEVELOPMENT CENTER 2012 - 2015

Paliperidone and Lithium in the Treatment of Suicidality - Treatment Indication and Epigenetic Regulation  awarded by American Foundation for Suicide Prevention 2012 - 2014

Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2014

Private Grant  awarded by CERECOR, INC. 2013 - 2014

Private Grant  awarded by Elan 2012 - 2014

2/2- Ziprasidone Augmentation of SSRIs for Treatment-Resistant Depression  awarded by National Institute of Mental Health/NIH/DHHS 2012 - 2014

2/4-A Genomic Approach to Schizophrenia  awarded by National Institute of Mental Health/NIH/DHHS 2009 - 2014

Private Grant  awarded by INNOPHARMA, INC. 2013 - 2014

Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2012 - 2013

Private Grant  awarded by Pfizer Pharmaceuticals 2011 - 2013

Private Grant  awarded by Pfizer Pharmaceuticals 2011 - 2013

Comparative Effectiveness of a Second Generation Antipsychotic Mood Stabilizer and a Classic Mood Stabilizer for Bipolar Disorder  awarded by MASSACHUSETTS GENERAL HOSPITAL 2012 - 2013

Private Grant  awarded by JANSSEN AI (ALZHEIMER IMMUNOTHERAPY) R&D 2008 - 2013